Abbott Launches Aveir Dual-Chamber Leadless Pacemaker in the UK
Abbott (NYSE: ABT) has reportedly begun rolling out its Aveir DR dual-chamber leadless pacemaker...
Read MoreSelect Page
Posted by Admin | Sep 10, 2024 | Devices, MedTech, Regulatory Update
Abbott (NYSE: ABT) has reportedly begun rolling out its Aveir DR dual-chamber leadless pacemaker...
Read MorePosted by Admin | Sep 8, 2024 | Health Economics, Regulatory, Regulatory Update
Welireg (belzutifan), developed by MSD (known as Merck & Co in the US and Canada), has...
Read More